Resolute Advisors’s Organon & Co OGN Stock Holding History

Resolute Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62	Closed	-$2K	–	422
2021 Q3	$2K	Hold	62	–	–	﹤0.01%	510
2021 Q2	$2K	Buy	+62	New	+$2.04K	﹤0.01%	482

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Resolute Advisors's OGN Position: Q4 2021 in Review

Resolute Advisors sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 62 shares — an estimated $2K sold.

Resolute Advisors first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

Resolute Advisors reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 62 Organon & Co shares in Q4 2021, an estimated $2K.
Resolute Advisors first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
Resolute Advisors's Organon & Co position peaked at $2K in Q3 2021.
907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.